What we can learn from nature to restore human vision
- 1Broad Institute , , ,
- 2Pediatric Neurology Department, N.F. Filatov Clinical Institute of Children's Health, Sechenov University , ,
- 3Neurocybernetics Lab, Russian Center of Neurology and Neurosciences , ,
Abstract
Irreversible vision loss, affecting millions of people worldwide, most often ends in the death of retinal neurons that the human eye cannot replace. Across the tree of life, however, evolution has repeatedly produced strategies that address the core problems of vision restoration: zebrafish and salamanders regenerate functional retinas and lenses, and a wide range of species have tuned photoreceptors, optics, and neural circuits to extract maximal information from light. This review systematizes these biological strategies and evaluates how each is being translated toward human therapies, with grading of the strength of evidence behind every translational claim. We organize the field by biological strategy: regeneration, spectral tuning, low-light adaptation, high-acuity optics, polarization and additional channels, and neural processing, and for each trace the path from mechanism to therapy or device. The most mature translations are already clinical: gene therapy for inherited retinal disease, and optogenetic restoration of vision in blind patients. Regenerative approaches informed by regenerating species, including Müller glia reprogramming, ciliary marginal zone biology, retinal organoids, and stem cell transplantation, are advancing toward clinical feasibility. Spectral, low-light, and acuity specializations provide mechanistic blueprints and bio-inspired devices, though their biological translation to humans remains preclinical or theoretical. We conclude with the controversies, research gaps, and ethical considerations that will shape whether nature's strategies can be safely and equitably applied to restore human vision, and we briefly consider the evidence and limits of extending vision beyond its native range.
Related
- On Color and Emotion: What Can Vision Science Learn from the Rorschach?
- A genome-scale ORF screen for resilience factors that protect the RPE and restore vision in aged mice
- Xenocortical mice: what can we learn, and how should this research progress?
- What’s taking so long for conscious vision?
- What Language Adds, and at What Cost: Four Controlled Probes of Pathology Vision-Language Models
BibTeX
@article{weener2026what,
title = {{What we can learn from nature to restore human vision}},
author = {Marianna Weener and Lusine Khachatryan and Boris Baziyan},
journal = {Frontiers in human neuroscience},
year = {2026},
month = oct,
doi = {10.3389/fnhum.2026.1968351},
url = {https://europepmc.org/article/PMC/PMC13730396},
note = {CC BY},
}
RIS
TY - JOUR
TI - What we can learn from nature to restore human vision
AU - Marianna Weener
AU - Lusine Khachatryan
AU - Boris Baziyan
PY - 2026
DA - 2026/10/20
JO - Frontiers in human neuroscience
DO - 10.3389/fnhum.2026.1968351
UR - https://europepmc.org/article/PMC/PMC13730396
AB - Irreversible vision loss, affecting millions of people worldwide, most often ends in the death of retinal neurons that the human eye cannot replace. Across the tree of life, however, evolution has repeatedly produced strategies that address the core problems of vision restoration: zebrafish and salamanders regenerate functional retinas and lenses, and a wide range of species have tuned photoreceptors, optics, and neural circuits to extract maximal information from light. This review systematizes these biological strategies and evaluates how each is being translated toward human therapies, with grading of the strength of evidence behind every translational claim. We organize the field by biological strategy: regeneration, spectral tuning, low-light adaptation, high-acuity optics, polarization and additional channels, and neural processing, and for each trace the path from mechanism to therapy or device. The most mature translations are already clinical: gene therapy for inherited retinal disease, and optogenetic restoration of vision in blind patients. Regenerative approaches informed by regenerating species, including Müller glia reprogramming, ciliary marginal zone biology, retinal organoids, and stem cell transplantation, are advancing toward clinical feasibility. Spectral, low-light, and acuity specializations provide mechanistic blueprints and bio-inspired devices, though their biological translation to humans remains preclinical or theoretical. We conclude with the controversies, research gaps, and ethical considerations that will shape whether nature's strategies can be safely and equitably applied to restore human vision, and we briefly consider the evidence and limits of extending vision beyond its native range.
SN - 1662-5161
ER -